Author: Alan Brochstein, CFA
The publicly-traded cannabis stocks have enjoyed an immense rally that began on 9/1, fueled by speculation regarding this week’s legalization ballot initiatives in Arizona, California, Maine, Massachusetts and Nevada along with...
More than six months ahead of the May 6, 2017 deadline for adoption, the Ohio Department of Commerce has issued proposed rules for cultivators in the Ohio Medical Marijuana Control...
Cannabis stocks have rallied dramatically in the past two months, with the Cannabis Stock Index more than doubling from the end of August, rising 136% from 33.16 on 8/31 to...
On June 1, 2015, Governor Greg Abbott of Texas signed the state’s “Compassionate Use Program”, Senate Bill 339, into law. One of the most restrictive medical cannabis programs in the...
After what seems like an unacceptably long delay, Health Canada, which oversees the Canadian medical cannabis program, ACMPR, reported data for the quarter ending 06/30/16 on Friday. The number of patients enrolled in...
One of the most interesting panels at the recent New West Summit was a presentation by Dr. Jonathan Cachat of Fleurish Farms about new sunlight capture cultivation technology that Fleurish Farms...
I had the privilege of moderating a panel on publicly-traded cannabis stocks at the recent New West Summit in San Francisco. The goal of the discussion was to help...
The highly successful New West Summit in San Francisco this past weekend included a panel “Canada’s Cannabis Legalization” that I moderated with a goal of informing attendees about the opportunities...
Cannabis stocks are on fire. The last time I wrote about the cannabis stock rally, the index was just above 40, up 22.1% YTD through September 23rd. Today, less...
A veteran of the Health Care Real Estate Investor Trust (REIT), Alan Gold, has created what will soon be the first publicly-traded cannabis REIT, Innovative Industrial Properties. The company,...
Cannabis stocks have been on quite the tear, with the index almost doubling from the levels near the end of August as traders gravitate to the sector in front of...
Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) announced another capital raise today, engaging Canaccord Genuity to help it raise up to $25mm through a private placement of 10% convertible notes that...
Goldman Sachs initiated coverage on GW Pharma (NASDAQ: GWPH) (AIM: GWP) on October 7th, with a “Buy” rating and a target of $189. The target was based on blend...
Since 2007, Global Alpha Forum has been bringing together hundreds of Alternative Investment professionals, offering panels and one-on-one meetings with a goal of covering the current state of the...
Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) announced today that it accelerated the exercise of 5.77mm warrants, most of which were exercisable at $0.66, associated with a capital raise that...
There is little doubt that cannabidiol (CBD) has medicinal benefits. Sanjay Gupta brought this into the mainstream in 2013 with his famous reversal, and, three years later, GW Pharma (NASDAQ:...
With voters weighing in on an unprecedented number of cannabis legalization ballot initiatives in just 40 days, media attention is starting to ramp up. This year, Arizona, California, Maine, Massachusetts and...
Shares in Indoor Harvest (OTC: INQD) soared Wednesday following news that Chuck Rifici, co-founder of Tweed, had injected capital into the company. Rifici, who is also a Director at...
We reported a serious threat to Terra Tech (OTC: TRTC) shareholders last month. The California-based company with cannabis operations in California and Nevada and produce operations in New Jersey, which...
Following its $23mm equity raise that closed in August, Aurora Cannabis (CSE: ACB) (OTC: ACBFF) has closed a $15mm convertible note private placement offering announced earlier this month. The...
In episode 44 of Investing in Cannabis, Brandon David interviews David Goldstein, CEO of Potbotics, which markets a “virtual budtender”, the PotBot, and a wireless EEG (electroencephalography) helmet that allows...
Clone Shipper, which we reported earlier this year had raised $300K through members of the Arcview Group, has signed a letter of intent to sell itself to Canadian licensed...
With just a week to go, it’s been a September to remember for cannabis stock traders, with the Cannabis Stock Index up 22.1% month-to-date: Volume has picked up as...
Pax Labs is extending its premium product line to take advantage of the trend towards cannabis concentrates by introducing the Pax Era vaporizer. The product, which retails for $59.99, is...
In August, we reported that an advisory board to the Supreme Court of Ohio recommended that attorneys in the state not be permitted to serve clients pursuing licenses in...
